Clinical Trial Update: Clinical Study of BR105 Injection [Phase 1]

View source ↗

Summary

A Phase 1 clinical study of BR105 Injection for advanced malignancies has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• BR105 Injection (BR105)

Snippet

Sponsor: BioRay Pharmaceutical Co., Ltd. | Conditions: Advanced Malignancies | Phase 1 | Status: TERMINATED